Michael E. Ray

University of Michigan–Ann Arbor — United States

Medicine · Health Sciences

25h-index2.5kcitations46works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(16), Prostate Cancer Diagnosis and Treatment(12), Advanced Radiotherapy Techniques(12), Sarcoma Diagnosis and Treatment(10), Vascular Tumors and Angiosarcomas(4)

Publications46 total

Data from Inhibition of mTOR Radiosensitizes Soft Tissue Sarcoma and Tumor Vasculature
2023Open Access
Supplementary Data from Inhibition of mTOR Radiosensitizes Soft Tissue Sarcoma and Tumor Vasculature
2023Open Access
Supplementary Data from Inhibition of mTOR Radiosensitizes Soft Tissue Sarcoma and Tumor Vasculature
2023Open Access
Data from Inhibition of mTOR Radiosensitizes Soft Tissue Sarcoma and Tumor Vasculature
2023Open Access
Merit-Based Incentive Payment System (MIPS) Participation in Radiation Oncology Practices — A Simple Survey
International Journal of Radiation Oncology*Biology*Physics·2020· 2 cited
Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO and AUA Evidence-Based Guideline
The Journal of Urology·2019· 85 cited
Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline
The Journal of Urology·2018· 64 cited
Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO, and AUA Evidence-Based Guideline
Practical Radiation Oncology·2018· 226 citedOpen Access
Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline
Journal of Clinical Oncology·2018· 172 citedOpen Access
Quality Improvements of Veterans Health Administration Radiation Oncology Services Through Partnership for Accreditation With the ACR
Journal of the American College of Radiology·2018· 7 cited
A phase 2 trial of salvage radiation and concurrent weekly docetaxel after a rising prostate-specific antigen level after radical prostatectomy
Advances in Radiation Oncology·2015· 7 citedOpen Access
Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy
Radiation Oncology·2012· 57 citedOpen Access
Risk Factors for Local Recurrence and Metastasis in Soft Tissue Sarcomas of the Extremity
American Journal of Clinical Oncology·2011· 59 cited
Potential Surrogate Endpoints for Prostate Cancer Survival: Analysis of a Phase III Randomized Trial
JNCI Journal of the National Cancer Institute·2009· 40 citedOpen Access
Inhibition of mTOR Radiosensitizes Soft Tissue Sarcoma and Tumor Vasculature
Clinical Cancer Research·2009· 43 citedOpen Access
No Effect of Statins on Biochemical Outcomes After Radiotherapy for Localized Prostate Cancer
Urology·2008· 56 cited
Loss of Raf Kinase Inhibitory Protein Induces Radioresistance in Prostate Cancer
International Journal of Radiation Oncology*Biology*Physics·2008· 48 citedOpen Access
Gemcitabine-Mediated Radiosensitization of Human Soft Tissue Sarcoma
Translational Oncology·2008· 18 citedOpen Access
Impact of Common Iliac Nodal Treatment on Radiation Outcomes in Localized Prostate Cancer
Urology·2008· 4 cited
Long-Term Outcomes After Radiotherapy for Retroperitoneal and Deep Truncal Sarcoma
International Journal of Radiation Oncology*Biology*Physics·2007· 62 cited
page 1 of 3Next →

Frequent Co-authors

Howard M. Sandler(12), Daniel A. Hamstra(8), Sonja M. Markwart(6), Aaron C. Spalding(6), Yash R. Somnay(6), James D. Murphy(5), Paul S. Meltzer(4), Jeffrey M. Trent(4), Scott C. Morgan(4), Karen E. Hoffman(4), D.A. Loblaw(4), Mark K. Buyyounouski(4), Caroline Delbourgo Patton(4), Daniel A. Barocas(4), Søren M. Bentzen(4), Jason A. Efstathiou(4), Patrick Greany(4), Per H. Halvorsen(4), Bridget F. Koontz(4), C.M. Leyrer(4)